1. Home
  2. REAL vs INBX Comparison

REAL vs INBX Comparison

Compare REAL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$9.20

Market Cap

1.1B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$102.31

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
INBX
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
999.7M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
REAL
INBX
Price
$9.20
$102.31
Analyst Decision
Buy
Buy
Analyst Count
8
3
Target Price
$17.00
$150.00
AVG Volume (30 Days)
3.9M
489.3K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
43.55
N/A
EPS
N/A
N/A
Revenue
$692,845,000.00
$1,300,000.00
Revenue This Year
$14.30
N/A
Revenue Next Year
$10.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.38
550.00
52 Week Low
$4.71
$12.80
52 Week High
$17.39
$155.29

Technical Indicators

Market Signals
Indicator
REAL
INBX
Relative Strength Index (RSI) 38.92 45.50
Support Level $8.05 $99.20
Resistance Level $11.48 $153.14
Average True Range (ATR) 0.69 13.75
MACD -0.21 -3.93
Stochastic Oscillator 10.64 8.06

Price Performance

Historical Comparison
REAL
INBX

About REAL The RealReal Inc.

The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: